This Article Full Text Full Text (PDF) All Versions of this Article: 51/1/8    most recent HYPERTENSIONAHA.107.099424v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Z. V. Articles by Scherer, P. E. Search for Related Content PubMed PubMed Citation Articles by Wang, Z. V. Articles by Scherer, P. E. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Obesity Type 2 diabetes

(Hypertension. 2008;51:8.)
© 2008 American Heart Association, Inc.

Brief Reviews

Adiponectin, Cardiovascular Function, and Hypertension

From the Department of Cell Biology (Z.V.W.), Albert Einstein College of Medicine, Bronx, NY; and the Touchstone Diabetes Center (Z.V.W., P.E.S.), Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

Correspondence to Philipp E. Scherer, Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8549. E-mail Philipp.Scherer@utsouthwestern.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Hypertension is a major risk factor for cardiovascular disease, and the latter is the leading cause of morbidity and mortality worldwide. In developed countries, hypertension ranks as the top contributing factor for mortality and third in causing disability-adjusted life years.¹ Hypertension is a polygenic and complex disease with rising prevalence. More than 25% of the adult population is affected by hypertension, and two thirds of those individuals reside in developing countries.² Europe shows an even higher prevalence of hypertension than North America.³ With the present trends, the prevalence of hypertension is predicted to increase to 30%, or 1.5 billion people, on the globe in the next 20 years.² Mechanistically, endothelial dysfunction, increased renin-angiotensin system (RAS) activity, and sympathetic nervous system (SNS) hyperactivation have been considered as important risk factors of hypertension and hint at important events taking place at the interface of the endothelium, kidney, and SNS.

Obesity is a global epidemic in children and adults. In the United States, a steady increase of the prevalence of obesity has been found in all states.^4,5 It is estimated that 65% of the population is overweight, which is judged by body mass index of 25.0 to 29.9, and 30% are obese (body mass index of 30.0).⁶ These numbers have been continuously rising in the past 15 years.⁷ The National Health and Nutrition Examination Survey III for 18 000 adults found that body mass index is an associated risk factor for hypertension independent of age, sex, race, and smoking.⁸ A long-term weight/hypertension relationship . . . [Full Text of this Article]

This article has been cited by other articles:

				K. Sodhi, K. Inoue, K. H. Gotlinger, M. Canestraro, L. Vanella, D. H. Kim, V. L. Manthati, S. R. Koduru, J. R. Falck, M. L. Schwartzman, et al. Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null Mice J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 906 - 916. [Abstract] [Full Text] [PDF]

				C. Marchesi, T. Ebrahimian, O. Angulo, P. Paradis, and E. L. Schiffrin Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome Hypertension, December 1, 2009; 54(6): 1384 - 1392. [Abstract] [Full Text] [PDF]

				N. G. Abraham, J. Cao, D. Sacerdoti, X. Li, and G. Drummond Heme oxygenase: the key to renal function regulation Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1137 - F1152. [Abstract] [Full Text] [PDF]

				W. L. Holland and P. E. Scherer PAQRs: A Counteracting Force to Ceramides? Mol. Pharmacol., April 1, 2009; 75(4): 740 - 743. [Abstract] [Full Text] [PDF]

				A. S. Greenstein, K. Khavandi, S. B. Withers, K. Sonoyama, O. Clancy, M. Jeziorska, I. Laing, A. P. Yates, P. W. Pemberton, R. A. Malik, et al. Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients Circulation, March 31, 2009; 119(12): 1661 - 1670. [Abstract] [Full Text] [PDF]

				K. Rahmouni and C. D. Sigmund Id3, E47, and SREBP-1c: Fat Factors Controlling Adiponectin Expression Circ. Res., September 12, 2008; 103(6): 565 - 567. [Full Text] [PDF]